Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zoomax is a global leader in the development and manufacturing of assistive technology for individuals with visual impairments. The company specializes in a diverse range of low-vision solutions, including handheld, portable, and desktop video magnifiers, as well as advanced wearable electronic glasses. Their flagship wearable product line, Acesight, employs augmented reality (AR) technology to help users with significant vision loss regain independence in daily activities. Zoomax products are designed to assist patients suffering from conditions such as age-related macular degeneration, glaucoma, and diabetic retinopathy. Founded in 2011 and headquartered in Hangzhou, China, the company maintains a strong international presence with distribution in over 60 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zoomax.